quinacrine has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geromichalos, GD; Harkitis, P; Karamanakos, PN; Konstandi, M; Marselos, M; Pappas, P; Trafalis, DT | 1 |
1 other study(ies) available for quinacrine and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Article | Year |
---|---|
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
Topics: Adult; Animals; Antimutagenic Agents; Binding Sites; Blotting, Western; Cytochrome P-450 CYP2E1 Inhibitors; Disulfiram; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Humans; Isoniazid; Male; Models, Molecular; Mutagens; Nitrosamines; Protein Binding; Quinacrine; Rats; Rats, Wistar; Sister Chromatid Exchange | 2009 |